AI Biotech Enveda Doubles in Value to $2 Billion
Backed by a former J&J CEO, the startup plans to advance its drug candidates into late-stage trials.
Connecting Global Economies
Flash News
AI Biotech Enveda Doubles in Value to $2 Billion
UK’s Burnham congratulates Trump and Danish PM on Greenland deal
Zelenskyy calls for trilateral meeting with Putin, Trump
Dancing With the Stars’ Jackson Olson’s Fake Teeth Explained
Gadgets Are Going Premium—and Manufacturers Are Raking It In
South Africa mass shooting leaves 11 dead, 3 wounded
South Korea seeks Trump summit with North Korea to promote peace
Heated Rivalry Star Hudson Williams’ Girlfriend Katelyn Larson Slams Fans
‘Disaster’: Germany’s embattled chancellor suffers bruising election defeats
Soybeans, planes and rare earths signify fragile U.S.-China trade truce
Wednesday, September 23, 2026
